Cost-effectiveness analysis, budget impact modelling, discrete choice experiments, and interactive R Shiny tools — delivered to pharma, HTA bodies, and research institutions across Europe.
"Implementation choices can shift the ICER more than the drug price itself."
End-to-end analytical support — from model design to interactive stakeholder tools.
Markov cohort models, partitioned survival, decision trees. Full PSA with tornado diagrams and CEACs. Excel or interactive R Shiny.
Multi-treatment BIA with population cascades, market share projections, and 7-layer cost modelling. Interactive payer engagement tools.
Full DCE pipeline: attribute identification, D-efficient design (Ngene), mixed logit & latent class, WTP estimation, interactive platforms.
Custom R Shiny tools that make your models accessible to HTA committees, payers, and clinical working groups. Deployed and production-ready.
Global value dossiers, systematic reviews, evidence packages for multi-jurisdiction submissions. Clinical evidence extraction to final deliverable.
Health economics research from protocol to peer-reviewed publication. Manuscript writing, preprint submission, systematic reviews. Focus areas include Alzheimer's, neurology, and chronic disease.
Deployed, working decision support tools — not mockups. Click to explore.
Disease-agnostic platform with Attribute Editor, CSV upload, real-time market simulation, WTP, and budget impact.
9-attribute simulation-based DCE for DMT implementation. Preferences, WTP, market simulation, economic evaluation.
5-state Markov comparing lecanemab & donanemab. HIQA-aligned, 10,000 PSA iterations.
PROM integration for atrial fibrillation care. ESC 2024 AF-CARE framework. 9 countries.
Cost-effectiveness model based on 121-patient time-study from three Nefro Klīnika facilities.
Open-source code for all dashboards, models, and tools.
Showing 5 of 19 publications including co-authored journal articles, book chapters, and conference presentations.
Request Full List →I work with pharmaceutical companies, HTA bodies, and research institutions across Europe.
Start a ConversationWhether you need a CEA for an HTA submission, an interactive dashboard for payer engagement, or a DCE to quantify patient preferences — I deliver production-ready work on time.